Literature DB >> 1722314

Deletion in erythrocyte band 3 gene in malaria-resistant Southeast Asian ovalocytosis.

P Jarolim1, J Palek, D Amato, K Hassan, P Sapak, G T Nurse, H L Rubin, S Zhai, K E Sahr, S C Liu.   

Abstract

Southeast Asian ovalocytosis (SAO) is a hereditary condition that is widespread in parts of Southeast Asia. The ovalocytic erythrocytes are rigid and resistant to invasion by various malarial parasites. We have previously found that the underlying defect in SAO involves band 3 protein, the major transmembrane protein, which has abnormal structure and function. We now report two linked mutations in the erythrocyte band 3 gene in SAO: (i) a deletion of codons 400-408 and (ii) a substitution, A----G, in the first base of codon 56 leading to substitution of Lys-56 by Glu-56. The first defect leads to a deletion of nine amino acids in the boundary of cytoplasmic and membrane domains of band 3. This defect has been detected in all 30 ovalocytic subjects from Malaysia, the Philippines, and two unrelated coastal regions of Papua New Guinea, whereas it was absent in all 30 controls from Southeast Asia and 20 subjects of different ethnic origin from the United States. The Lys-56----Glu substitution has likewise been found in all SAO subjects. However, it has also been detected in 5 of the 50 control subjects, suggesting that it represents a linked polymorphism. We conclude that the deletion of codons 400-408 in the band 3 gene constitutes the underlying molecular defect in SAO.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722314      PMCID: PMC53065          DOI: 10.1073/pnas.88.24.11022

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Human erythrocyte Band-3 has an altered N terminus in malaria-resistant Melanesian ovalocytosis.

Authors:  G L Jones; H M Edmundson; D Wesche; A Saul
Journal:  Biochim Biophys Acta       Date:  1990-11-14

2.  DNA in heritable disease.

Authors:  B C Sykes
Journal:  Lancet       Date:  1983-10-01       Impact factor: 79.321

3.  DNA analysis in the diagnosis of hemoglobin disorders.

Authors:  M Goossens; Y Y Kan
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

4.  Rigid membranes of Malayan ovalocytes: a likely genetic barrier against malaria.

Authors:  N Mohandas; L E Lie-Injo; M Friedman; J W Mak
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

5.  Malaria and ovalocytosis--molecular mimicry?

Authors:  A Husain-Chishti; P Ruff
Journal:  Biochim Biophys Acta       Date:  1991-04-15

6.  Selective depression of blood group antigens associated with hereditary ovalocytosis among melanesians.

Authors:  P B Booth; S Serjeantson; D G Woodfield; D Amato
Journal:  Vox Sang       Date:  1977       Impact factor: 2.144

7.  Resistance of Melanesian elliptocytes (ovalocytes) to invasion by Plasmodium knowlesi and Plasmodium falciparum malaria parasites in vitro.

Authors:  T Hadley; A Saul; G Lamont; D E Hudson; L H Miller; C Kidson
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

8.  Ovalocytosis in Papua New Guinea -- dominantly inherited resistance to malaria.

Authors:  D Castelino; A Saul; P Myler; C Kidson; H Thomas; R Cooke
Journal:  Southeast Asian J Trop Med Public Health       Date:  1981-12       Impact factor: 0.267

9.  Ovalocytic erythrocytes from Melanesians are resistant to invasion by malaria parasites in culture.

Authors:  C Kidson; G Lamont; A Saul; G T Nurse
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

10.  Decreased membrane deformability in Melanesian ovalocytes from Papua New Guinea.

Authors:  A Saul; G Lamont; W H Sawyer; C Kidson
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

View more
  69 in total

1.  Flexibility of the cytoplasmic domain of the anion exchange protein, band 3, in human erythrocytes.

Authors:  S M Blackman; E J Hustedt; C E Cobb; A H Beth
Journal:  Biophys J       Date:  2001-12       Impact factor: 4.033

2.  Distribution of a 27-bp deletion in the band 3 gene in South Pacific islanders.

Authors:  Masako Kimura; Moedrik Tamam; Augustinus Soemantri; Minato Nakazawa; Yuji Ataka; Ryutaro Ohtsuka; Takafumi Ishida
Journal:  J Hum Genet       Date:  2003-11-15       Impact factor: 3.172

3.  High prevalence of Southeast Asian ovalocytosis in Malays with distal renal tubular acidosis.

Authors:  Narazah Mohd Yusoff; Hans Van Rostenberghe; Taku Shirakawa; Kaoru Nishiyama; Noryati Amin; Zainal Darus; Nik Zainal; Nizam Isa; Hiroyuki Nozu; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2003-11-15       Impact factor: 3.172

4.  Fetal anaemia from red blood cell membrane defect and co-inherited haemoglobin Constant Spring.

Authors:  Kasemsri Srisupundit; Pimlak Charoenkwan; Kuntharee Traisrisilp; Theera Tongsong
Journal:  BMJ Case Rep       Date:  2015-07-27

Review 5.  Population genetics of malaria resistance in humans.

Authors:  P W Hedrick
Journal:  Heredity (Edinb)       Date:  2011-03-23       Impact factor: 3.821

6.  Neonatal anemia associated with Southeast Asian ovalocytosis.

Authors:  Vichai Laosombat; Supaporn Dissaneevate; Malai Wongchanchailert; Benjamas Satayasevanaa
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

Review 7.  About hemoglobins, G6PD and parasites in red cells.

Authors:  L Luzzatto
Journal:  Experientia       Date:  1995-03-15

Review 8.  Red blood cell polymorphism and susceptibility to Plasmodium vivax.

Authors:  Peter A Zimmerman; Marcelo U Ferreira; Rosalind E Howes; Odile Mercereau-Puijalon
Journal:  Adv Parasitol       Date:  2013       Impact factor: 3.870

9.  Trafficking defects of the Southeast Asian ovalocytosis deletion mutant of anion exchanger 1 membrane proteins.

Authors:  Joanne C Cheung; Emmanuelle Cordat; Reinhart A F Reithmeier
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

Review 10.  Red cell membrane: past, present, and future.

Authors:  Narla Mohandas; Patrick G Gallagher
Journal:  Blood       Date:  2008-11-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.